Evidence map›Paper›PMID 34654821›Full record

ArticleNature communications2021

A C. elegans model of C9orf72-associated ALS/FTD uncovers a conserved role for eIF2D in RAN translation.

Yoshifumi Sonobe, Jihad Aburas, Gopinath Krishnan, Andrew C Fleming, Ghanashyam Ghadge, Priota Islam, Eleanor C Warren, Yuanzheng Gu, Mark W Kankel, André E X Brown and 5 more

Open access · goldAbstract read
In one paragraph

Article in Nature communications, 2021. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 31 papers.

0numbers the graph read from it
0cells of the map it votes in
31citing papers in PubMed
3.6field-weighted citation impact, top 6% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

31 citing papers in PubMed, 49 citations in OpenAlex.

  1. Article
  2. Article
  3. Article
  4. Article
  5. Article
  6. Article
  7. Cryptic intronic transcriptional initiation generates efficient endogenous mRNA templates for C9orf72-associated RAN translation.Proceedings of the National Academy of Sciences of the United States of America · 2025
    Article
  8. Review
  9. Unraveling Molecular Targets for Neurodegenerative Diseases ThroughInternational journal of molecular sciences · 2025
    Review
  10. Article
  11. Article
  12. Review
  13. ALS' Perfect Storm:Cells · 2024
    Review
  14. Review
  15. Towards Understanding Neurodegenerative Diseases: Insights fromInternational journal of molecular sciences · 2023
    Review
  16. Article
  17. Article
  18. Article
  19. Article
  20. Article
4 · The record

Corrections and comments

5 · Who and what money

Authors and funding

15 authors at 7 institutions in 2 countries.

Yoshifumi SonobeUniversity of Chicago Medical Center, 5841S. Maryland Avenue, Chicago, IL, 60637, USA.ORCID 0000-0001-7738-8902
Jihad AburasUniversity of Chicago Medical Center, 5841S. Maryland Avenue, Chicago, IL, 60637, USA.ORCID 0000-0001-6608-3513
Gopinath KrishnanDepartment of Neurology, University of Massachusetts Medical School, Worcester, MA, 01605, USA.
Andrew C FlemingThe Ken & Ruth Davee Department of Neurology, Feinberg School of Medicine, Northwestern University, Chicago, USA.ORCID 0000-0002-5889-871X
Ghanashyam GhadgeUniversity of Chicago Medical Center, 5841S. Maryland Avenue, Chicago, IL, 60637, USA.
Priota IslamMRC London Institute of Medical Sciences, London, UK.
Eleanor C WarrenMRC London Institute of Medical Sciences, London, UK.
Yuanzheng GuNeuromuscular & Movement Disorders, Biogen, Cambridge, MA, 02142, USA.ORCID 0000-0003-1493-1167
Mark W KankelNeuromuscular & Movement Disorders, Biogen, Cambridge, MA, 02142, USA.ORCID 0000-0001-7837-8044
André E X BrownMRC London Institute of Medical Sciences, London, UK.
Evangelos KiskinisThe Ken & Ruth Davee Department of Neurology, Feinberg School of Medicine, Northwestern University, Chicago, USA.
Tania F GendronDepartment of Neuroscience, Mayo Clinic, Jacksonville, FL, USA.ORCID 0000-0002-7335-2627
Fen-Biao GaoDepartment of Neurology, University of Massachusetts Medical School, Worcester, MA, 01605, USA.ORCID 0000-0001-8873-5404
Raymond P Roos *University of Chicago Medical Center, 5841S. Maryland Avenue, Chicago, IL, 60637, USA. rroos@neurology.bsd.uchicago.edu.ORCID 0000-0002-0613-4048
Paschalis Kratsios *University of Chicago Medical Center, 5841S. Maryland Avenue, Chicago, IL, 60637, USA. pkratsios@uchicago.edu.ORCID 0000-0002-1363-9271
University of Chicago · USMRC London Institute of Medical Sciences · GBBiogen (United States) · USNorthwestern University · USUniversity of Massachusetts Chan Medical School · USMayo Clinic in Florida · USUniversity of Illinois Chicago · US

Funding

Enhancing and expanding the CGC Strain CollectionP40OD010440 · OD · UNIVERSITY OF MINNESOTA · PI Aric L Daul, Ann E. Rougvie · 2012 to 2026
$7.5M
Investigating Common Molecular Pathogenic Pathways in Frontotemporal Dementia Patients iPSC-Derived NeuronsR01NS057553 · NINDS · UNIV OF MASSACHUSETTS MED SCH WORCESTER · PI Fen-Biao Gao · 2008 to 2026
$4.5M
Investigating Pathogenic Mechanisms of Frontotemporal Dementia Caused by Mutations in CHMP2B and TBK1R37NS057553 · NINDS · UNIV OF MASSACHUSETTS MED SCH WORCESTER · PI GAO, FEN-BIAO · 2018 to 2024
$4.3M
Understanding Frontotemporal Dementia Using Drosophila and iPSC ModelsR01NS101986 · NINDS · UNIV OF MASSACHUSETTS MED SCH WORCESTER · PI Fen-Biao Gao · 2017 to 2026
$3.6M
Determining How Defective Nucleo-Cytoplasmic Trafficking Leads To Neurodegeneration In C9orf72-Related ALS And FTDR01NS104219 · NINDS · NORTHWESTERN UNIVERSITY AT CHICAGO · PI KISKINIS, EVANGELOS · 2018 to 2022
$2.3M
Medical Research Council MC_UP_1102/6NIH HHS P40 OD010440NINDS NIH HHS R01 NS057553NINDS NIH HHS R01 NS101986NINDS NIH HHS R01 NS104219NINDS NIH HHS R37 NS057553
6 · The paper itself

Abstract

A hexanucleotide repeat expansion GGGGCC in the non-coding region of C9orf72 is the most common cause of inherited amyotrophic lateral sclerosis (ALS) and frontotemporal dementia (FTD). Toxic dipeptide repeats (DPRs) are synthesized from GGGGCC via repeat-associated non-AUG (RAN) translation. Here, we develop C. elegans models that express, either ubiquitously or exclusively in neurons, 75 GGGGCC repeats flanked by intronic C9orf72 sequence. The worms generate DPRs (poly-glycine-alanine [poly-GA], poly-glycine-proline [poly-GP]) and poly-glycine-arginine [poly-GR]), display neurodegeneration, and exhibit locomotor and lifespan defects. Mutation of a non-canonical translation-initiating codon (CUG) upstream of the repeats selectively reduces poly-GA steady-state levels and ameliorates disease, suggesting poly-GA is pathogenic. Importantly, loss-of-function mutations in the eukaryotic translation initiation factor 2D (eif-2D/eIF2D) reduce poly-GA and poly-GP levels, and increase lifespan in both C. elegans models. Our in vitro studies in mammalian cells yield similar results. Here, we show a conserved role for eif-2D/eIF2D in DPR expression.

Indexed as

AlanineAmyotrophic Lateral SclerosisAnimalsArginineC9orf72 ProteinCaenorhabditis elegansDipeptidesFemaleFrontotemporal DementiaGene EditingGene Knockdown TechniquesGlycineHEK293 CellsHumansMiddle AgedMotor NeuronsAlanineArginineC9orf72 ProteinDipeptidesGlycineProline

Identifiers

PMID34654821
PMCPMC8519953
OpenAlexW3207762575

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.